BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 6, 2003
View Archived Issues
Abraxane exceeds primary efficacy objective in phase III trial
Read More
Aripiprazole in schizophrenia and bipolar disorder
Read More
Treatment completed in phase IIb trial of MBI-594AN for acne
Read More
Positive phase I results for Cytovaxine
Read More
Biogen licenses rights to oral psoriasis product from Fumapharm
Read More
FDA approves Zomig nasal spray
Read More
BCY LifeSciences completes treatment in phase II DCF-987 trial
Read More
VaxGen awarded anthrax vaccine development contract by NIAID
Read More
Atomoxetine hydrochloride in children and adults with ADHD
Read More
Lack of synergy described for alendronate and PTH in osteoporosis
Read More
Novel NPY Y5 antagonists prepared and tested at Roche
Read More
Recent patents cover new 5-HT6 modulators for psychosis, other CNS disorders and imaging
Read More
New antibacterial oxazolidinones discovered at P&U (now Pfizer)
Read More
Bayer presents two novel series of antitumor agents in recent patent literature
Read More
Schering presents new contrast agents for X-ray and NMR
Read More
Novel PI3-kinase inhibitors and their use described by Novartis scientists
Read More
Abbott seeks approval for Humira for improvement of physical function in RA
Read More
Rolling NDA submission continues for RSR-13
Read More
Arius and PDL enter cancer antibody development partnership
Read More
Medarex and Trillium collaborate on development of antibody therapeutics
Read More
Preclinical update provided for ENT-103
Read More
Neuprex tested for potential in pediatric open heart surgery
Read More
Forest discontinues development of dexloxiglumide for constipation-predominant IBS
Read More
Potential new amyloid-imaging agent presented to Japanese Society of Dementia
Read More
Anti-HIV candidate with unique resistance profile and promising pharmacokinetics
Read More
Inhaled ilomastat prevents cigarette smoke-induced lung damage in mouse model of emphysema
Read More
Novel antibacterial agents targeting enoyl-ACP reductase
Read More